Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

被引：755
|
作者：
Rupprecht, Rainer [1 ,2 ]
Papadopoulos, Vassilios [3 ,4 ,5 ,6 ,7 ]
Rammes, Gerhard [2 ,8 ]
Baghai, Thomas C. [1 ]
Fan, Jinjiang [3 ,4 ,5 ,6 ,7 ]
Akula, Nagaraju [9 ]
Groyer, Ghislaine [10 ,11 ]
Adams, David [12 ]
Schumacher, Michael [10 ,11 ]
机构：
[1] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
[3] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada
[5] McGill Univ, Dept Pharmacol, Montreal, PQ H3G 1A4, Canada
[6] McGill Univ, Dept Therapeut, Montreal, PQ H3G 1A4, Canada
[7] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada
[8] Tech Univ Munich, Dept Anesthesiol, D-81675 Munich, Germany
[9] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA
[10] INSERM, UMR 788, F-94276 Le Kremlin Bicetre, France
[11] Univ Paris 11, F-94276 Le Kremlin Bicetre, France
[12] Hop Bicetre, AP HP, Dept Neurol, F-94276 Le Kremlin Bicetre, France
来源：
NATURE REVIEWS DRUG DISCOVERY | 2010年 / 9卷 / 12期
基金：
加拿大健康研究院;
关键词：
PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; CENTRAL-NERVOUS-SYSTEM; EXTRASYNAPTIC GABA(A) RECEPTORS; ADULT SEPARATION ANXIETY; DEPENDENT ANION CHANNEL; MICROGLIAL ACTIVATION; CHOLESTEROL TRANSPORT; IN-VITRO; NEUROACTIVE STEROIDS;
D O I：
10.1038/nrd3295
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The translocator protein (18 kDa) (TSPO) is localized primarily in the outer mitochondrial membrane of steroid-synthesizing cells, including those in the central and peripheral nervous system. One of its main functions is the transport of the substrate cholesterol into mitochondria, a prerequisite for steroid synthesis. TSPO expression may constitute a biomarker of brain inflammation and reactive gliosis that could be monitored by using TSPO ligands as neuroimaging agents. Moreover, initial clinical trials have indicated that TSPO ligands might be valuable in the treatment of neurological and psychiatric disorders. This Review focuses on the biology and pathophysiology of TSPO and the potential of currently available TSPO ligands for the diagnosis and treatment of neurological and psychiatric disorders.
引用
收藏
页码：971 / 988
页数：18
相关论文
共 50 条
  • [41] Translocator Protein 18 kDa (TSPO): A Promising Molecular Target for Image-Guided Surgery of Solid Cancers
    Wongso, Hendris
    Kurniawan, Ahmad
    Setiadi, Yanuar
    Kusumaningrum, Crhisterra E.
    Widyasari, Eva M.
    Wibawa, Teguh H. A.
    Mahendra, Isa
    Febrian, Muhamad B.
    Sriyani, Maula E.
    Halimah, Iim
    Daruwati, Isti
    Gunawan, Rudi
    Achmad, Arifudin
    Nugraha, Dwianto H.
    Lesmana, Ronny
    Nugraha, Ari S.
    ADVANCED PHARMACEUTICAL BULLETIN, 2024, 14 (01) : 86 - 104
  • [42] ONO-2952, a novel translocator protein 18kDa antagonist, exhibits anti-stress effects: TSPO as new therapeutic target for stress related disorders
    Katsumata, Seishi
    Mitsui, Katsukuni
    Niwa, Tomohiro
    Kawahara, Yuji
    Nakanisi, Noriko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S175 - S175
  • [43] Stress Sensitivity in Patients with Atopic Dermatitis in Relation to the Translocator Protein 18 kDa (TSPO)
    Kaga, Mio
    Nakamoto, Yurie
    Nakamura, Kazuhiko
    Ikeda, Kazutaka
    Yoshii, Mitsunobu
    Kawana, Seiji
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2014, 81 (03) : 148 - 156
  • [44] Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression
    Riebel, Marco
    Brunner, Lisa-Marie
    Nothdurfter, Caroline
    Wein, Simon
    Schwarzbach, Jens
    Liere, Philippe
    Schumacher, Michael
    Rupprecht, Rainer
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024,
  • [45] Translocator Protein 18 kDa (TSPO) Is Regulated in White and Brown Adipose Tissue by Obesity
    Thompson, Misty M.
    Manning, H. Charles
    Ellacott, Kate L. J.
    PLOS ONE, 2013, 8 (11):
  • [46] Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands
    Falchi, Angela Maria
    Battetta, Barbara
    Sanna, Francesca
    Piludu, Marco
    Sogos, Valeria
    Serra, Mariangela
    Melis, Marta
    Putzolu, Martina
    Diaz, Giacomo
    NEUROPHARMACOLOGY, 2007, 53 (02) : 318 - 329
  • [47] Evidence for Complex Binding Profiles and Species Differences at the Translocator Protein (TSPO) (18 kDa)
    Scarf, A. M.
    Luus, C.
    Da Pozzo, E.
    Selleri, S.
    Guarino, C.
    Martini, C.
    Ittner, L. M.
    Kassiou, M.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (04) : 488 - 493
  • [48] Is there Any Correlation Between Binding and Functional Effects at the Translocator Protein (TSPO) (18 kDa)?
    Scarf, A. M.
    Auman, K. M.
    Kassiou, M.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (04) : 387 - 397
  • [49] Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
    Ching, Alex Sik Chung
    Kuhnast, Bertrand
    Damont, Annelaure
    Roeda, Dirk
    Tavitian, Bertrand
    Dolle, Frederic
    INSIGHTS INTO IMAGING, 2012, 3 (01): : 111 - 119
  • [50] Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
    Alex Sik Chung Ching
    Bertrand Kuhnast
    Annelaure Damont
    Dirk Roeda
    Bertrand Tavitian
    Frédéric Dollé
    Insights into Imaging, 2012, 3 (1) : 111 - 119
12345